Safety and efficacy of neublastin in painful lumbosacral radiculopathy: A randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial)
Pain Aug 29, 2017
Backonja M, et al. – Safety and efficacy of neublastin were investigated in painful lumbosacral radiculopathy. The physicians found no clear dose–response relationship for pain reduction or the most common adverse event of pruritus, while this study revealed some evidence of pain relief with neublastin, especially at the lowest dose.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries